We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXDX
1076
DELISTED
Accelerate Diagnostics
AXDX
$23K ﹤0.01%
1,579
+496
+46% +$14.1K
RVI
1077
DELISTED
Retail Value Inc. Common Shares
RVI
$22K ﹤0.01%
7,268
-3,016
-29% -$9.52K
EXEL icon
1078
Exelixis
EXEL
$13.9B
$21K ﹤0.01%
923
GH icon
1079
Guardant Health
GH
$19.1B
$20K ﹤0.01%
297
OUT icon
1080
Outfront Media
OUT
$5.75B
$20K ﹤0.01%
728
QQQN
1081
DELISTED
VictoryShares Nasdaq Next 50 ETF
QQQN
$19K ﹤0.01%
663
-73,550
-99% -$2.16M
BNS icon
1082
Scotiabank
BNS
$105B
$17K ﹤0.01%
235
MEDP icon
1083
Medpace
MEDP
$16.3B
$17K ﹤0.01%
105
PRQR icon
1084
ProQR Therapeutics
PRQR
$244M
$17K ﹤0.01%
18,877
+5,860
+45% +$19.6K
ITCI
1085
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$17K ﹤0.01%
277
+39
+16% +$2.02K
PEI
1086
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$17K ﹤0.01%
1,785
+530
+42% +$7.07K
AQN icon
1087
PUT
Algonquin Power & Utilities
AQN
$4.59B
$16K ﹤0.01%
760
-183
-19% -$2.64K
HALO icon
1088
Halozyme
HALO
$9.88B
$16K ﹤0.01%
411
NTLA icon
1089
Intellia Therapeutics
NTLA
$1.51B
$16K ﹤0.01%
217
APLS
1090
DELISTED
Apellis Pharmaceuticals
APLS
$15K ﹤0.01%
298
CM icon
1091
Canadian Imperial Bank of Commerce
CM
$106B
$15K ﹤0.01%
250
+100
+67% +$6.31K
IONS icon
1092
Ionis Pharmaceuticals
IONS
$8.93B
$15K ﹤0.01%
412
ARWR icon
1093
Arrowhead Research
ARWR
$12.1B
$14K ﹤0.01%
305
MRVI icon
1094
Maravai LifeSciences
MRVI
$972M
$14K ﹤0.01%
384
RARE icon
1095
Ultragenyx Pharmaceutical
RARE
$2.46B
$14K ﹤0.01%
199
MRTX
1096
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$13K ﹤0.01%
161
ALKS icon
1097
Alkermes
ALKS
$8.11B
$12K ﹤0.01%
472
TWOU
1098
PUT
DELISTED
2U Inc
TWOU
$12K ﹤0.01%
+33
New +$13.3K
ACAD icon
1099
Acadia Pharmaceuticals
ACAD
$4.51B
$11K ﹤0.01%
469
BEAM icon
1100
Beam Therapeutics
BEAM
$2.68B
$11K ﹤0.01%
199

Similar funds

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.